abrdn plc lowered its stake in shares of Koninklijke Philips (NYSE:PHG - Free Report) by 17.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 98,347 shares of the technology company's stock after selling 20,339 shares during the period. abrdn plc's holdings in Koninklijke Philips were worth $3,218,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the stock. Allspring Global Investments Holdings LLC acquired a new position in Koninklijke Philips in the first quarter worth approximately $40,000. Fairscale Capital LLC acquired a new position in shares of Koninklijke Philips during the 2nd quarter worth $54,000. Eastern Bank acquired a new position in shares of Koninklijke Philips during the 3rd quarter worth $88,000. CWM LLC raised its holdings in shares of Koninklijke Philips by 21.9% during the 2nd quarter. CWM LLC now owns 3,429 shares of the technology company's stock valued at $86,000 after purchasing an additional 616 shares in the last quarter. Finally, Blue Trust Inc. lifted its stake in shares of Koninklijke Philips by 902.7% in the 2nd quarter. Blue Trust Inc. now owns 3,700 shares of the technology company's stock valued at $93,000 after purchasing an additional 3,331 shares during the last quarter. 13.67% of the stock is currently owned by hedge funds and other institutional investors.
Koninklijke Philips Stock Performance
PHG traded up $0.59 during trading on Monday, hitting $27.08. The stock had a trading volume of 1,154,975 shares, compared to its average volume of 988,691. The firm has a market cap of $25.45 billion, a PE ratio of -64.55, a P/E/G ratio of 0.92 and a beta of 0.77. The company has a current ratio of 1.16, a quick ratio of 0.74 and a debt-to-equity ratio of 0.60. Koninklijke Philips has a 12 month low of $19.49 and a 12 month high of $32.91. The company has a 50 day simple moving average of $30.78 and a 200-day simple moving average of $28.00.
Wall Street Analyst Weigh In
Several research firms have weighed in on PHG. StockNews.com upgraded Koninklijke Philips from a "hold" rating to a "buy" rating in a report on Monday, July 15th. Jefferies Financial Group upgraded Koninklijke Philips from an "underperform" rating to a "hold" rating in a report on Tuesday, October 29th. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold".
Get Our Latest Stock Report on Koninklijke Philips
Koninklijke Philips Profile
(
Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Articles
Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.